Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04571619
Status:
COMPLETED
Last Update Posted:
2024-06-06
First Post:
2020-09-15
Brief Title:
HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Study Overview
Official Title:
A Randomized Clinical Trial to Evaluate Non-Pharmacologic and Pharmacologic Approaches for Reducing Pain and Opioid Use Among Patients Treated With Maintenance Hemodialysis
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HOPE
Brief Summary:
HOPE is a randomized clinical trial that will evaluate approaches to reducing pain and opioid use among patients with chronic pain who are receiving maintenance hemodialysis for end-stage renal disease The hypothesis is that pain coping skills training will be effective at reducing pain and opioid use and that buprenorphine will be acceptable and tolerable as an approach to managing physical dependence on opioids in this patient population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U01DK123813 | NIH | None | None |
| U01DK123786 | NIH | None | None |
| U01DK123787 | NIH | None | None |
| U01DK123812 | NIH | None | None |
| U01DK123814 | NIH | None | None |
| U01DK123816 | NIH | None | None |
| U01DK123817 | NIH | None | None |
| U01DK123818 | NIH | None | None |
| U01DK123821 | NIH | None | httpsreporternihgovquickSearchU01DK123821 |